In the present study we tested the protective effects of
netrin-1 in
stroke and investigated the potential underlying mechanisms. When we performed
middle cerebral artery occlusion (MCAO) on adult mice, up-regulation of the receptor uncoordinated gene 5H2 (UNC5H2) but not its
ligand netrin-1 was detected with RT-PCR and immunohistochemistry. Injection of
netrin-1, 1 day after MCAO, significantly reduced
infarct volume at 3 days after MCAO as revealed by functional magnetic resonance imaging. The ischemic cortex was preserved when
netrin-1 was continuously administered.
Fluoro-Jade and
terminal deoxynucleotidyl transferase-mediated
digoxigenin-dUTP-
biotin nick-end labeling staining showed that
netrin-1 reduced the number of dying neurons and apoptotic cells after MCAO.
Ischemia-induced p53 expression was attenuated by
netrin-1. We also tested the ability of
netrin-1 to attract intrinsic neuronal stem cells to the
infarct area. Both DCC and UNC5H2 were expressed in neurosphere culture and
netrin-1 attracted stem cells in an in vitro transwell assay. However, in vivo
netrin-1 administration did not enhance the MCAO-induced stem cell migration toward the
infarct area. Our study shows that UNC5H2 expression was elevated after MCAO and administration of
netrin-1 protected
infarct tissue from p53-mediated apoptosis. These data indicate that the p53/dependent receptor pathway is involved in
ischemic stroke pathology and suggest possible new
stroke therapies.